New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg - film coated tablet - 450 mg - active: valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg excipient: crospovidone microcrystalline cellulose opadry brown 15b565009 purified water stearic acid - for the treatment of cytomegalovirus (cmv) retinitis in acquired immunodeficiency syndrome (aids) patients. for the prevention of cmv disease in solid organ transplant patients at risk.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg - solution for infusion - 5 mg/100ml - active: zoledronic acid monohydrate 5.33mg equivalent to zolendronic acid (anhydrous) 5mg excipient: mannitol sodium citrate water for injection - · treatment of osteoporosis in postmenopausal women to reduce the incidence of hip, vertebral and non-vertebral fractures and to increase bone mineral density. · prevention of postmenopausal osteoporosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid monohydrate; purified talc - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting): - hearing loss (hardness of hearing): - tinnitus.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100mg/ml;   - concentrate for infusion - 200 mcg/2ml - active: dexmedetomidine hydrochloride 0.118 mg/ml equivalent to dexmedetomidine 0.100mg/ml   excipient: sodium chloride water for injection - icu sedation: for sedation of initially intubated patients during treatment in an intensive care setting. the use of dexmedetomidine viatris by continuous infusion in these patients should not exceed 24 hours. procedural sedation: for sedation of non-intubated patients prior to and/or during surgical and other procedures.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - bisacodyl 5mg - enteric coated tablet - 5 mg - active: bisacodyl 5mg excipient: carnauba wax hyprolose hypromellose methacrylic acid copolymer, eudragit s 100 iron oxide yellow isopropyl alcohol lactose monohydrate magnesium stearate   methacrylic acid copolymer microcrystalline cellulose purified talc purified water   starch sucrose titanium dioxide triethyl citrate - short term relief of constipation

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - metoprolol tartrate 5mg - solution for injection - 5 mg/5ml - active: metoprolol tartrate 5mg excipient: sodium chloride water for injection - disturbances of cardiac rhythm, including supraventricular and ventricular arrhythmias.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - abacavir sulfate 702.78mg equivalent to abacavir 600 mg;  ; lamivudine 300mg - film coated tablet - active: abacavir sulfate 702.78mg equivalent to abacavir 600 mg   lamivudine 300mg excipient: colloidal silicon dioxide crospovidone magnesium stearate microcrystalline cellulose opadry white 13b58894 purified talc silicified microcrystalline cellulose - antiretroviral combination therapy for the treatment of hiv in adults and adolescents from 12 years of age.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous) - film coated tablet - 0.5 mg - active: entecavir monohydrate 0.53mg equivalent to 0.5 mg entecavir (anhydrous) excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1r-7003 purified water - entecavir is indicated for the treatment of chronic hbv infection in adults with evidence of active liver inflammation.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - entecavir monohydrate 1.06mg equivalent to 1 mg entecavir (anhydrous) - film coated tablet - 1 mg - active: entecavir monohydrate 1.06mg equivalent to 1 mg entecavir (anhydrous) excipient: crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose opadry white ys-1r-7003 purified water - entecavir is indicated for the treatment of chronic hbv infection in adults with evidence of active liver inflammation.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - domperidone maleate 12.72mg equivalent to domperidone 10 mg - tablet - 10 mg - active: domperidone maleate 12.72mg equivalent to domperidone 10 mg excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate maize starch microcrystalline cellulose povidone purified water sodium laurilsulfate - treatment of acute symptoms of nausea and vomiting.